Go Ad-Free
    My Alerts
    Budget Express 2026

    co-presented by

    • LIC
    • JIO BlackRock

    ASSOCIATE SPONSORS

    • Sunteck
    • SBI
    • Emirates
    • Dezerv
    Trending Topics

    business

    Buy Dr Reddy's; Divis Lab, Biocon good bets: IIFL Cap

    Concentrating on the pharma space, Bino Pathiparampil of IIFL Capital told CNBC-TV18 the success of Biocon‘s oral insulin product deal would be a positive for the company. He also has a buy on Dr Reddy‘s and believes it should give a 25 percent plus upside in the next one year.

    first published: Nov 20, 2012 12:20 pm

    LATEST VIDEOS

    Watch More →

    A collection of the most-viewed Moneycontrol videos.

    Watch and Follow our leading shows

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347